NDC11 00054033425
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00054-0334-25 | 00054-0334 |
| 00054-334-25 | 00054-334 |
| 0054-0334-25 | 0054-0334 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cevimeline Hydrochloride | CEVIMELINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 1167360c-7e0f-4619-9d1a-ad4ee56cab71 | 2024-01-08 | Warnings, Adverse reactions | 0054-0334-25 0054-0334 00054033425 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.